Pricing Log in Create free account
Saturday 17 October 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

235.00 4.15 −1.74%
Market cap
$26.4B
P/E
24.6×
Fwd P/E
20.8×
Dividend yield
1.44%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Quest Diagnostics Incorporated (DGX) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Quest Diagnostics Incorporated (DGX) trades at a EV/EBITDA of 14.1×. Over the past ten years it has ranged from 6.4× (June 2021) to 14.7× (September 2026); the current reading is higher than 99% of that period. That is below the Diagnostics & Research industry median of 24.3× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 11.5× (5.40%)
FY2024 12.2× 4.71%
FY2023 11.6× (0.12%)
FY2022 11.7× 31.24%
FY2021 8.9× 10.00%
FY2020 8.1× (29.60%)
FY2019 11.5× 7.19%
FY2018 10.7× (10.74%)
FY2017 12.0× 12.07%
FY2016 10.7× 32.32%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 12.9× 5.25%
Mar 2026 12.3× 6.42%
Dec 2025 11.5× (9.32%)
Sep 2025 12.7× 0.73%
42 more quarters

Against its own ten years

Low 6.4× High 14.7×
Ten-year median 11.3×
Current reading's percentile 99

EV/EBITDA against peers

Company EV/EBITDA
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated 14.1×
LH Labcorp Holdings Inc. compare 14.5×
RVTY Revvity Inc. compare 24.8×
MTD Mettler-Toledo International, Inc. compare 26.6×
IDXX IDEXX Laboratories, Inc. compare 27.6×
MEDP Medpace Holdings, Inc. compare 27.9×
ILMN Illumina, Inc. compare 35.0×
WAT Waters Corporation compare 50.1×
Diagnostics & Research industry median 24.3×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on DGX